Literature DB >> 21184743

Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.

Shigeru Morimura1, Katsuo Suzuki, Kazuhide Takahashi.   

Abstract

Investigation of the mechanism underlying cell membrane-targeted WAVE2 capture by phosphatidylinositol 3,4,5-triphosphate (PIP(3)) through IRSp53 revealed an unidentified 250-kDa protein (p250) bound to PIP(3). We identified p250 as nonmuscle myosin IIA heavy chain (MYH9) by mass spectrometry and immunoblot analysis using anti-MYH9 antibody. After stimulation with insulin-like growth factor I (IGF-I), MYH9 colocalized with PIP(3) in lamellipodia at the leading edge of cells. Depletion of MYH9 expression by small interfering RNA (siRNA) and inhibition of myosin II activity by blebbistatin abrogated the formation of actin filament (F-actin) arcs and lamellipodia induced by IGF-I. MYH9 was constitutively associated with WAVE2, which was dependent on myosin II activity, and the MYH9-WAVE2 complex colocalized to PIP(3) at the leading edge after IGF-I stimulation. These results indicate that MYH9 is required for lamellipodia formation since it provides contractile forces and tension for the F-actin network to form convex arcs at the leading edge through constitutive binding to WAVE2 and colocalization with PIP(3) in response to IGF-I.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184743     DOI: 10.1016/j.bbrc.2010.12.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Endothelial Cell Plasma Membrane Biomechanics Mediates Effects of Pro-Inflammatory Factors on Endothelial Mechanosensors: Vicious Circle Formation in Atherogenic Inflammation.

Authors:  Nadezhda Barvitenko; Mohammad Ashrafuzzaman; Alfons Lawen; Elisaveta Skverchinskaya; Carlota Saldanha; Alessia Manca; Giuseppe Uras; Muhammad Aslam; Antonella Pantaleo
Journal:  Membranes (Basel)       Date:  2022-02-10

2.  Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain.

Authors:  Xiong Liu; Shi Shu; Neil Billington; Chad D Williamson; Shuhua Yu; Hanna Brzeska; Julie G Donaldson; James R Sellers; Edward D Korn
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

3.  A Brucella virulence factor targets macrophages to trigger B-cell proliferation.

Authors:  Juan M Spera; Claudia K Herrmann; Mara S Roset; Diego J Comerci; Juan E Ugalde
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

4.  Reduced signaling of PI3K-Akt and RAS-MAPK pathways is the key target for weight-loss-induced cancer prevention by dietary calorie restriction and/or physical activity.

Authors:  Joseph Standard; Yu Jiang; Miao Yu; Xiaoyu Su; Zhihui Zhao; Jianteng Xu; Jie Chen; Brenee King; Lizhi Lu; John Tomich; Richard Baybutt; Weiqun Wang
Journal:  J Nutr Biochem       Date:  2014-09-22       Impact factor: 6.048

5.  WAVE2 Protein Complex Coupled to Membrane and Microtubules.

Authors:  Kazuhide Takahashi
Journal:  J Oncol       Date:  2012-01-18       Impact factor: 4.375

6.  Functions of nonmuscle myosin II in assembly of the cellular contractile system.

Authors:  Maria Shutova; Changsong Yang; Jury M Vasiliev; Tatyana Svitkina
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

7.  Prognostic significance of MYH9 expression in resected non-small cell lung cancer.

Authors:  Ken Katono; Yuichi Sato; Shi-Xu Jiang; Makoto Kobayashi; Ryo Nagashio; Shinichiro Ryuge; Eriko Fukuda; Naoki Goshima; Yukitoshi Satoh; Makoto Saegusa; Noriyuki Masuda
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

8.  Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study.

Authors:  Annelies Suetens; Marjan Moreels; Roel Quintens; Sabina Chiriotti; Kevin Tabury; Arlette Michaux; Vincent Grégoire; Sarah Baatout
Journal:  Int J Oncol       Date:  2014-02-03       Impact factor: 5.650

Review 9.  Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?

Authors:  Yunmei Wang; Shuguang Liu; Yanjun Zhang; Jin Yang
Journal:  Med Sci Monit       Date:  2019-01-31

10.  Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis.

Authors:  Hui Yao; Jiangang Liu; Chi Zhang; Yunxiang Shao; Xuetao Li; Zhengquan Yu; Yulun Huang
Journal:  Cell Death Dis       Date:  2021-10-11       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.